Contact this trialFirst, we need to learn more about you.
Bruton's Tyrosine Kinase Inhibitor
Remibrutinib for Myasthenia Gravis
Recruiting1 awardPhase 3
Buffalo, New York
"This trial is testing whether Remibrutinib is effective and safe for adults with Generalized Myasthenia Gravis compared to a placebo. Participants must already be on standard treatment for the condition
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service